TEENAGE boys aren’t famous for expressing their feelings. But as my son Jeremiah sweeps me up into a hug and thanks me, I know he isn’t happy about a new game or pair of trainers. He’s talking ...
Middle-class Indians trying to lose weight are embracing drugs such as Mounjaro, which is also used to treat diabetes in a ...
IF you’ve ever searched for weight loss tips online, you will know the deep rabbit hole that awaits. But now, social media ...
Russian teenagers are turning to a viral weight-loss pill named Molecule. This pill, sold illegally, contains a banned ...
Lilly’s quarterly results Thursday, combined with Novo Nordisk’s unsolicited offer for a startup, confirm the $72 billion ...
One writer felt she'd finally reached her bodily happy ever after via GLP-1 jabs. But with soaring prices and scientific unknowns on the horizon...now what?
JCPenney and Ashley Graham defy the Ozempic trend with a bold, size-inclusive campaign that celebrates curves and drives ...
IT’S almost impossible to imagine a time when the words ‘Ozempic’ and ‘Mounjaro’ weren’t part of our vocabulary. For years, celebrities have embraced the “skinny ...
BRITS are being warned to watch out for fake fat jabs after a mum died from one she bought at a salon in Manchester. Karen ...
Zacks Investment Research on MSN
NVO vs. GPCR: Which Obesity Stock is the Better Buy Right Now?
Novo Nordisk NVO and Structure Therapeutics GPCR have emerged as noteworthy companies in the obesity space. A market leader in the GLP-1 space, Novo Nordisk markets its semaglutide drugs under brand ...
Share on Pinterest Experts say California’s new affordable insulin program is a breakthrough for people with diabetes. Getty Images California has launched a program to manufacture and sell lower-cost ...
Share on Pinterest The “golden dose” left in Mounjaro or Ozempic pens may do more harm than good, according to experts. Design by MNT; Photography by Bloomberg/Getty Images Over the last few years, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results